• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ENEIDA 登记研究(炎症性肠病的遗传和环境决定因素的全国性研究):GETECCU 的设计、监测和功能。

The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions.

机构信息

Hospital Universitari Mútua Terrassa, Tarrasa (Barcelona), España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España; Hospital Clinic i Provincial de Barcelona, IDIBAPS, Barcelona, España.

出版信息

Gastroenterol Hepatol. 2020 Nov;43(9):551-558. doi: 10.1016/j.gastrohep.2020.05.007. Epub 2020 Jul 14.

DOI:10.1016/j.gastrohep.2020.05.007
PMID:32674882
Abstract

The ENEIDA registry, promoted by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU), was created in 2005 by a group of gastroenterologists interested in improving the management of patients with inflammatory bowel disease. The main objectives of the registry were to facilitate the collection of clinical data of interest for clinical care practice, as well as to carry out collaborative studies using clinical data and biological samples. In its 15 years of existence, ENEIDA has evolved in many aspects, from its content or technological support to the number of participating centres, to become one of the reference registries for the study and care of patients with inflammatory bowel disease, with a continuous and high quality scientific production that has positioned it as an example of collaborative scientific exploitation at an international level. This article reviews the objectives, design, structural characteristics, monitoring and scientific exploitation of the ENEIDA registry.

摘要

ENEIDA 注册表由西班牙克罗恩病和溃疡性结肠炎工作组(GETECCU)于 2005 年创建,由一群对改善炎症性肠病患者管理感兴趣的胃肠病学家组成。该注册表的主要目标是促进收集对临床护理实践有意义的临床数据,并利用临床数据和生物样本开展合作研究。在其 15 年的存在期间,ENEIDA 在许多方面都有所发展,无论是从内容或技术支持,还是从参与中心的数量方面,它都已成为炎症性肠病研究和护理的参考注册表之一,具有持续的高质量科学产出,将其定位为国际合作科学开发的典范。本文回顾了 ENEIDA 注册表的目标、设计、结构特征、监测和科学开发。

相似文献

1
The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions.ENEIDA 登记研究(炎症性肠病的遗传和环境决定因素的全国性研究):GETECCU 的设计、监测和功能。
Gastroenterol Hepatol. 2020 Nov;43(9):551-558. doi: 10.1016/j.gastrohep.2020.05.007. Epub 2020 Jul 14.
2
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease.西班牙炎症性肠病工作组关于性行为与炎症性肠病的立场声明
Gastroenterol Hepatol. 2024 Aug-Sep;47(7):774-792. doi: 10.1016/j.gastrohep.2023.12.013. Epub 2024 Jan 11.
3
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.炎症性肠病患者的肠外表现:基于 ENEIDA 登记研究。
Dig Dis Sci. 2021 Jun;66(6):2014-2023. doi: 10.1007/s10620-020-06424-x. Epub 2020 Jul 15.
4
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.拉丁美洲炎症性肠病综合护理门诊质量指标共识:PANCCO-GETECCU。
Rev Gastroenterol Mex (Engl Ed). 2022 Jan-Mar;87(1):89-102. doi: 10.1016/j.rgmxen.2021.05.013. Epub 2021 Dec 3.
5
Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease.西班牙初级保健医师学会(SEMERGEN)和西班牙克罗恩病和溃疡性结肠炎工作组(GETECCU)关于炎症性肠病患者管理的调查。
Gastroenterol Hepatol. 2023 Oct;46(8):647-656. doi: 10.1016/j.gastrohep.2022.10.023. Epub 2022 Nov 17.
6
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.西班牙克罗恩病和溃疡性结肠炎工作组(GETECCU)以及克罗恩病和溃疡性结肠炎患者协会(ACCU)关于炎症性肠病患者心理问题管理的建议。
Gastroenterol Hepatol. 2018 Feb;41(2):118-127. doi: 10.1016/j.gastrohep.2017.10.003. Epub 2017 Dec 21.
7
Recommendations of the Spanish Working Group on Crohn's disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients.西班牙炎症性肠病工作组(Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU)关于炎症性肠病患者异型增生筛查的建议。
Gastroenterol Hepatol. 2021 Jun-Jul;44(6):435-447. doi: 10.1016/j.gastrohep.2020.12.011. Epub 2021 Feb 13.
8
Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?抗 TNF 药物给药间隔延长:炎症性肠病患者的有效策略?
Dig Dis Sci. 2020 Jul;65(7):2036-2043. doi: 10.1007/s10620-019-06010-w. Epub 2019 Dec 19.
9
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.类固醇难治性急性重度溃疡性结肠炎患者术后发病率和死亡率:GETECCU ENEIDA 注册全国多中心研究。
Am J Gastroenterol. 2018 Jul;113(7):1009-1016. doi: 10.1038/s41395-018-0057-0. Epub 2018 May 1.
10
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.西班牙克罗恩病和溃疡性结肠炎工作组(GETECCU)关于硫唑嘌呤在炎症性肠病中应用的建议。
Gastroenterol Hepatol. 2018 Mar;41(3):205-221. doi: 10.1016/j.gastrohep.2017.11.007. Epub 2018 Jan 19.

引用本文的文献

1
Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post-Authorisation Safety Study Using the Spanish ENEIDA Registry.接受戈利木单抗治疗的溃疡性结肠炎患者的结肠切除术及肿瘤转归:一项使用西班牙ENEIDA注册库的上市后安全性研究
Pharmacoepidemiol Drug Saf. 2025 Aug;34(8):e70176. doi: 10.1002/pds.70176.
2
Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.家族性炎症性肠病病史对生物治疗时代儿童发病的炎症性肠病患者使用免疫抑制剂、生物制剂及手术的影响。来自ENEIDA注册研究的结果
J Clin Med. 2025 May 12;14(10):3352. doi: 10.3390/jcm14103352.
3
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.临床前炎症性肠病的自然史、免疫学及遗传学特征(EARLY):一项前瞻性队列研究的研究方案
Therap Adv Gastroenterol. 2025 May 12;18:17562848251338647. doi: 10.1177/17562848251338647. eCollection 2025.
4
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials.目标试验模拟:运用随机试验原则提高炎症性肠病观察性研究的质量
Inflamm Bowel Dis. 2025 Mar 3;31(3):843-849. doi: 10.1093/ibd/izae131.
5
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.炎症性肠病靶向治疗的使用趋势:ENEIDA的TRENDY研究
Pharmaceutics. 2024 May 8;16(5):629. doi: 10.3390/pharmaceutics16050629.
6
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.接受两种连续抗TNF药物治疗的溃疡性结肠炎患者使用第二种皮下或静脉注射抗TNF药物的临床及治疗结局:来自ENEIDA注册研究的数据
Therap Adv Gastroenterol. 2024 Jan 5;17:17562848231221713. doi: 10.1177/17562848231221713. eCollection 2024.
7
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review.炎症性肠病中的内脏静脉血栓形成:来自ENEIDA注册研究的观察性研究及系统评价
J Clin Med. 2023 Nov 28;12(23):7366. doi: 10.3390/jcm12237366.
8
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study.炎症性肠病患者淋巴瘤的临床表现、管理及演变:一项ENEIDA注册研究
Cancers (Basel). 2023 Jan 25;15(3):750. doi: 10.3390/cancers15030750.
9
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).炎症性肠病中新冠病毒病的危险因素:一项基于西班牙炎症性肠病注册数据库(ENEIDA)的全国性病例对照研究(COVID-19-EII)
J Clin Med. 2022 Dec 19;11(24):7540. doi: 10.3390/jcm11247540.
10
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease.与克罗恩病不良预后相关的过氧化氢酶的遗传多样性和功能障碍。
Int J Mol Sci. 2022 Dec 14;23(24):15881. doi: 10.3390/ijms232415881.